New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity Hwang DJ et al., (J Med Chem 2019 Jan 24;62(2):491-511. PMID: 30525603).